SynCardia Facebook SynCardia Twitter SynCardia LInkedIn SynCardia Google Plus SynCardia Youtube

SynCardia Systems, Inc.

Press Release:

1st Turkish Total Artificial Heart Patient Discharged Using Freedom® Portable Driver

45-Year-Old Father of Three Discharged from Florence Nightingale Hospital in Istanbul to Wait for Matching Donor Heart at Home with Family

Omer Bayrak, pictured with his 12-year-old daughter Betül, is the first SynCardia Total Artificial Heart patient in Turkey to be discharged from the hospital using the Freedom® portable driver. Omer Bayrak, pictured with his 12-year-old daughter Betül, is the first SynCardia Total Artificial Heart patient in Turkey to be discharged from the hospital using the Freedom® portable driver. TUCSON, Ariz. – June 22, 2011 – SynCardia Systems, Inc. manufacturer of the SynCardia temporary Total Artificial Heart, announced today that Florence Nightingale Hospital in Istanbul has discharged Turkey's first Total Artificial Heart patient to wait for a matching donor heart at home using the Freedom® portable driver. Weighing 13.5 pounds, the Freedom driver is the world's first wearable portable driver designed to power SynCardia's Total Artificial Heart both inside and outside the hospital.

"Initially, we had concerns about switching our patient to the Freedom driver because he is really a big guy," said surgeon Prof. Dr. Deniz Suha Kucukaksu. "However, our patient experienced no differences with this wearable driver. We are excited to be able to discharge him with his Total Artificial Heart. The Freedom driver is so powerful that he can live a near normal life outside of the hospital while waiting for transplantation under safe conditions."

Omer Bayrak, 45, had been suffering from congestive heart failure since 2001. Four years ago, he underwent cardiac resynchronization therapy and received an implantable cardioverter-defibrillator (ICD). Last year, he was hospitalized 11 times for inotropic support. 

For 15 days prior to receiving SynCardia's Total Artificial Heart, Mr. Bayrak had been in the cardiac intensive care unit. He was on the urgent list for heart transplantation but his cardiac function continued to worsen. As a result, he became the hospital's first patient to receive SynCardia's Total Artificial Heart.

"I can do almost everything with my Freedom driver," said Mr. Bayrak, who was discharged from the hospital on May 20. "Although I have no biological heart, I still have emotions. Before this illness period, I was against organ donation, but now I understand the importance of it."

The Freedom portable driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S. SynCardia recognizes and thanks Ufuk Yaranli and Natura Medikal Urunler Ltd., the Turkish distributor for the Total Artificial Heart, for their commitment and on-going support of Florence Nightingale Hospital.

###

About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the temporary Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.

Follow SynCardia: Facebook | Twitter | LinkedIn | Google+

SynCardia Contact:
Janelle Drumwright, jdrumwright@syncardia.com, (520) 547-7463

Search offcanvas